Functional genomics of trypanosomatids

Parasite Immunology

Volumn 34, Issue 2-3, 2012, Pages 72-79

  Choi, J ^a   El Sayed, N M ^a  

^a University of Maryland   (United States)

Author keywords

Comparative; Genomics; Metabolome; Protein protein interactions; Proteome; Transcriptome; Trypanosomatids

Indexed keywords

DNA DIRECTED RNA POLYMERASE; MINICIRCLE DNA; RNA POLYMERASE II;

AFRICAN TRYPANOSOMIASIS; CELL CYCLE; CHAGAS DISEASE; CHROMATIN IMMUNOPRECIPITATION; DNA FINGERPRINTING; DNA MICROARRAY; EPIGENETICS; FLAGELLUM; FUNCTIONAL GENOMICS; GENE CLUSTER; GENE EXPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC VARIABILITY; GENOME; GLYCOSOME; GLYCOSYLATION; HISTONE ACETYLATION; KINETOPLASTIDA; LEISHMANIA BRAZILIENSIS; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; MASS SPECTROMETRY; MEGACOLON; MEGAESOPHAGUS; METABOLOMICS; MITOCHONDRION; NONHUMAN; PHYLOGENY; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; RNA INTERFERENCE; SKIN LEISHMANIASIS; TRYPANOSOMA CONGOLENSE; TRYPANOSOMA VIVAX;

ANIMALS; GENOME, PROTOZOAN; GENOMICS; HUMANS; PROTEOME; PROTOZOAN PROTEINS; TRANSCRIPTOME; TRYPANOSOMATINA;

KINETOPLASTIDA; LEISHMANIA MAJOR; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI; TRYPANOSOMATIDAE;

EID: 84863012787     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2011.01347.x     Document Type: Review

References (126)

1. World Health Organization. The Global Burden of Disease: 2004 Update. Geneva, WHO Press, 2008.
2. Lukes J, Guilbride DL, Votypka J, Zikova A, Benne R & Englund PT. Kinetoplast DNA network: evolution of an improbable structure. Eukaryot Cell 2002; 1: 495-502.
3. Brewster S, Aslett M & Barker DC. Kinetoplast DNA minicircle database. Parasitol Today 1998; 14: 437-438.
4. Boothroyd JC. Antigenic variation in African trypanosomes. Annu Rev Microbiol 1985; 39: 475-502.
5. Borst P, Rudenko G, Blundell PA, et al. Mechanisms of antigenic variation in African trypanosomes. Behring Inst Mitt 1997; 99: 1-15.
6. Donelson JE. A summary of the molecular biology of antigenic variation in African trypanosomes. Mem Inst Oswaldo Cruz 1988; 83(Suppl 1): 244-248.
7. Pays E. [Antigenic variation of African trypanosomes]. Ann Parasitol Hum Comp 1990; 65(Suppl 1): 5-10.
8. Campbell DA, Thomas S & Sturm NR. Transcription in kinetoplastid protozoa: why be normal? Microbes Infect 2003; 5: 1231-1240.
9. Stuart KD, Schnaufer A, Ernst NL & Panigrahi AK. 2005. Complex management: RNA editing in trypanosomes. Trends Biochem Sci 30: 97-105.
10. Opperdoes FR. The glycosome of trypanosomes and Leishmania. Biochem Soc Trans 1990; 18: 729-731.
11. Rudenko G, Lee MG & Van der Ploeg LH. The PARP and VSG genes of Trypanosoma brucei do not resemble RNA polymerase II transcription units in sensitivity to Sarkosyl in nuclear run-on assays. Nucleic Acids Res 1992; 20: 303-306.
12. Berriman M, Ghedin E, Hertz-Fowler C, et al. The genome of the African trypanosome Trypanosoma brucei. Science 2005; 309: 416-422.
13. El-Sayed NM, Myler PJ, Bartholomeu DC, et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 2005; 309: 409-415.
14. Ivens AC, Peacock CS, Worthey EA, et al. The genome of the kinetoplastid parasite Leishmania major. Science 2005; 309: 436-442.
15. El-Sayed NM, Myler PJ, Blandin G, et al. Comparative genomics of trypanosomatid parasitic protozoa. Science 2005; 309: 404-409.
16. Haag J, O'hUigin C & Overath P. The molecular phylogeny of trypanosomes: evidence for an early divergence of the Salivaria. Mol Biochem Parasitol 1998; 91: 37-49.
17. Lukes J, Jirku M, Dolezel D, Kral'ova I, Hollar L & Maslov DA. Analysis of ribosomal RNA genes suggests that trypanosomes are monophyletic. J Mol Evol 1997; 44: 521-527.
18. Stevens JR & Gibson WC. The evolution of pathogenic trypanosomes. Cad Saude Publica 1999; 15: 673-684.
19. Wright AD, Li S, Feng S, Martin DS & Lynn DH. Phylogenetic position of the kinetoplastids, Cryptobia bullocki, Cryptobia catostomi, and Cryptobia salmositica and monophyly of the genus Trypanosoma inferred from small subunit ribosomal RNA sequences. Mol Biochem Parasitol 1999; 99: 69-76.
20. Bartholomeu DC, Cerqueira GC, Leao AC, et al. Genomic organization and expression profile of the mucin-associated surface protein (masp) family of the human pathogen Trypanosoma cruzi. Nucleic Acids Res 2009; 37: 3407-3417.
21. Peacock CS, Seeger K, Harris D, et al. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet 2007; 39: 839-847.
22. Smith DF, Peacock CS & Cruz AK. Comparative genomics: from genotype to disease phenotype in the leishmaniases. Int J Parasitol 2007; 37: 1173-1186.
23. Lye LF, Owens K, Shi H, et al. Retention and loss of RNA interference pathways in trypanosomatid protozoans. PLoS Pathog 2010; 6: e1001161.
24. Jackson AP, Sanders M, Berry A, et al. The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human african trypanosomiasis. PLoS Negl Trop Dis 2010; 4: e658.
25. Hertz-Fowler C, Peacock CS, Wood V, et al. GeneDB: a resource for prokaryotic and eukaryotic organisms. Nucleic Acids Res 2004; 32: D339-D343.
26. Buck GA, Berriman M, Donelson JE, et al. 2007. Pathogenomics of trypanosomatid parasites.
27. Rassi A Jr, Rassi A & Marin-Neto JA. Chagas disease. Lancet 2010; 375: 1388-1402.
28. Clayton CE. Life without transcriptional control? From fly to man and back again. EMBO J 2002; 21: 1881-1888.
29. Holzer TR, McMaster WR & Forney JD. Expression profiling by whole-genome interspecies microarray hybridization reveals differential gene expression in procyclic promastigotes, lesion-derived amastigotes, and axenic amastigotes in Leishmania mexicana. Mol Biochem Parasitol 2006; 146: 198-218.
30. Cohen-Freue G, Holzer TR, Forney JD & McMaster WR. Global gene expression in Leishmania. Int J Parasitol 2007; 37: 1077-1086.
31. Leifso K, Cohen-Freue G, Dogra N, Murray A & McMaster WR. Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: the Leishmania genome is constitutively expressed. Mol Biochem Parasitol 2007; 152: 35-46.
32. Minning TA, Weatherly DB, Atwood J III, Orlando R & Tarleton RL. The steady-state transcriptome of the four major life-cycle stages of Trypanosoma cruzi. BMC Genomics 2009; 10: 370.
33. Kabani S, Fenn K, Ross A, et al. Genome-wide expression profiling of in vivo-derived bloodstream parasite stages and dynamic analysis of mRNA alterations during synchronous differentiation in Trypanosoma brucei. BMC Genomics 2009; 10: 427.
34. Saxena A, Lahav T, Holland N, et al. Analysis of the Leishmania donovani transcriptome reveals an ordered progression of transient and permanent changes in gene expression during differentiation. Mol Biochem Parasitol 2007; 152: 53-65.
35. Jensen BC, Sivam D, Kifer CT, Myler PJ & Parsons M. Widespread variation in transcript abundance within and across developmental stages of Trypanosoma brucei. BMC Genomics 2009; 10: 482.
36. Koumandou VL, Natesan SK, Sergeenko T & Field MC. The trypanosome transcriptome is remodelled during differentiation but displays limited responsiveness within life stages. BMC Genomics 2008; 9: 298.
37. Depledge DP, Evans KJ, Ivens AC, et al. Comparative expression profiling of Leishmania: modulation in gene expression between species and in different host genetic backgrounds. PLoS Negl Trop Dis 2009; 3: e476.
38. Shateri NH & Salavati R. Functional genome annotation by combined analysis across microarray studies of Trypanosoma brucei. PLoS Negl Trop Dis 2010; 4: e810.
39. Thomas S, Green A, Sturm NR, Campbell DA & Myler PJ. Histone acetylations mark origins of polycistronic transcription in Leishmania major. BMC Genomics 2009; 10: 152.
40. Mortazavi A, Williams BA, McCue K, Schaeffer L & Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008; 5: 621-628.
41. Wang Z, Gerstein M & Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009; 10: 57-63.
42. Siegel TN, Hekstra DR, Wang X, Dewell S & Cross GA. Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. Nucleic Acids Res 2010; 38: 4946-4957.
43. Kolev NG, Franklin JB, Carmi S, Shi H, Michaeli S & Tschudi C. The transcriptome of the human pathogen Trypanosoma brucei at single-nucleotide resolution. PLoS Pathog 2010; 6: e1001090.
44. Nilsson D, Gunasekera K, Mani J, et al. Spliced leader trapping reveals widespread alternative splicing patterns in the highly dynamic transcriptome of Trypanosoma brucei. PLoS Pathog 2010; 6: e1001037.
45. Veitch NJ, Johnson PC, Trivedi U, Terry S, Wildridge D & MacLeod A. Digital gene expression analysis of two life cycle stages of the human-infective parasite, Trypanosoma brucei gambiense reveals differentially expressed clusters of co-regulated genes. BMC Genomics 2010; 11: 124.
46. Li Q, Zhao Y, Ni B, et al. Comparison of the expression profiles of promastigotes and axenic amastigotes in Leishmania donovani using serial analysis of gene expression. Parasitol Res 2008; 103: 821-828.
47. Siegel TN, Hekstra DR, Kemp LE, et al. Four histone variants mark the boundaries of polycistronic transcription units in Trypanosoma brucei. Genes Dev 2009; 23: 1063-1076.
48. Elias MC & Faria M. Are there epigenetic controls in Trypanosoma cruzi? Ann N Y Acad Sci 2009; 1178: 285-290.
49. Ngo H, Tschudi C, Gull K & Ullu E. Double-stranded RNA induces mRNA degradation in Trypanosoma brucei. Proc Natl Acad Sci USA 1998; 95: 14687-14692.
50. Shi H, Djikeng A, Mark T, Wirtz E, Tschudi C & Ullu E. Genetic interference in Trypanosoma brucei by heritable and inducible double-stranded RNA. RNA 2000; 6: 1069-1076.
51. Subramaniam C, Veazey P, Redmond S, et al. Chromosome-wide analysis of gene function by RNA interference in the african trypanosome. Eukaryot Cell 2006; 5: 1539-1549.
52. Baker N, Alsford S & Horn D. Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6. Mol Biochem Parasitol 2011; 176: 55-57.
53. Schumann BG, Jutzi P & Roditi I. Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters. Mol Biochem Parasitol 2011; 175: 91-94.
54. Alsford S, Turner DJ, Obado SO, et al. High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome. Genome Res 2011; 21: 915-924.
55. DaRocha WD, Otsu K, Teixeira SM & Donelson JE. Tests of cytoplasmic RNA interference (RNAi) and construction of a tetracycline-inducible T7 promoter system in Trypanosoma cruzi. Mol Biochem Parasitol 2004; 133: 175-186.
56. Genovesio A, Giardini MA, Kwon YJ, et al. Visual genome-wide RNAi screening to identify human host factors required for Trypanosoma cruzi infection. PLoS ONE 2011; 6: e19733.
57. Atwood JA III, Weatherly DB, Minning TA, et al. The Trypanosoma cruzi proteome. Science 2005; 309: 473-476.
58. Roy N, Nageshan RK, Pallavi R, et al. Proteomics of Trypanosoma evansi infection in rodents. PLoS ONE 2010; 5: e9796.
59. Parodi-Talice A, Monteiro-Goes V, Arrambide N, et al. Proteomic analysis of metacyclic trypomastigotes undergoing Trypanosoma cruzi metacyclogenesis. J Mass Spectrom 2007; 42: 1422-1432.
60. Mojtahedi Z, Clos J & Kamali-Sarvestani E. Leishmania major: identification of developmentally regulated proteins in procyclic and metacyclic promastigotes. Exp Parasitol 2008; 119: 422-429.
61. Ferella M, Nilsson D, Darban H, et al. Proteomics in Trypanosoma cruzi- localization of novel proteins to various organelles. Proteomics 2008; 8: 2735-2749.
62. Colasante C, Ellis M, Ruppert T & Voncken F. Comparative proteomics of glycosomes from bloodstream form and procyclic culture form Trypanosoma brucei brucei. Proteomics 2006; 6: 3275-3293.
63. Cunha-E-Silva NL, Atella GC, Porto-Carreiro IA, Morgado-Diaz JA, Pereira MG & De SW. Isolation and characterization of a reservosome fraction from Trypanosoma cruzi. FEMS Microbiol Lett 2002; 214: 7-12.
64. Sant'Anna C, Nakayasu ES, Pereira MG, et al. Subcellular proteomics of Trypanosoma cruzi reservosomes. Proteomics 2009; 9: 1782-1794.
65. Hart SR, Lau KW, Hao Z, et al. Analysis of the trypanosome flagellar proteome using a combined electron transfer/collisionally activated dissociation strategy. J Am Soc Mass Spectrom 2009; 20: 167-175.
66. DeGrasse JA, Chait BT, Field MC & Rout MP. High-yield isolation and subcellular proteomic characterization of nuclear and subnuclear structures from trypanosomes. Methods Mol Biol 2008; 463: 77-92.
67. Bridges DJ, Pitt AR, Hanrahan O, et al. Characterisation of the plasma membrane subproteome of bloodstream form Trypanosoma brucei. Proteomics 2008; 8: 83-99.
68. Panigrahi AK, Ogata Y, Zikova A, et al. A comprehensive analysis of Trypanosoma brucei mitochondrial proteome. Proteomics 2009; 9: 434-450.
69. Atwood JA III, Minning T, Ludolf F, et al. Glycoproteomics of Trypanosoma cruzi trypomastigotes using subcellular fractionation, lectin affinity, and stable isotope labeling. J Proteome Res 2006; 5: 3376-3384.
70. Nakayasu ES, Yashunsky DV, Nohara LL, Torrecilhas AC, Nikolaev AV & Almeida IC. GPIomics: global analysis of glycosylphosphatidylinositol-anchored molecules of Trypanosoma cruzi. Mol Syst Biol 2009; 5: 261.
71. Holzmuller P, Biron DG, Courtois P, et al. Virulence and pathogenicity patterns of Trypanosoma brucei gambiense field isolates in experimentally infected mouse: differences in host immune response modulation by secretome and proteomics. Microbes Infect 2008; 10: 79-86.
72. Holzmuller P, Grebaut P, Peltier JB, et al. Secretome of animal trypanosomes. Ann N Y Acad Sci 2008; 1149: 337-342.
73. Silverman JM, Chan SK, Robinson DP, et al. Proteomic analysis of the secretome of Leishmania donovani. Genome Biol 2008; 9: R35.
74. Atyame Nten CM, Sommerer N, Rofidal V, et al. Excreted/secreted proteins from trypanosome procyclic strains. J Biomed Biotechnol 2010; 2010: 212817.
75. Nett IR, Martin DM, Miranda-Saavedra D, et al. The phosphoproteome of bloodstream form Trypanosoma brucei, causative agent of African sleeping sickness. Mol Cell Proteomics 2009; 8: 1527-1538.
76. Morales MA, Watanabe R, Dacher M, et al. Phosphoproteome dynamics reveal heat-shock protein complexes specific to the Leishmania donovani infectious stage. Proc Natl Acad Sci USA 2010; 107: 8381-8386.
77. Brenchley R, Tariq H, McElhinney H, et al. The TriTryp phosphatome: analysis of the protein phosphatase catalytic domains. BMC Genomics 2007; 8: 434.
78. da Cunha JP, Nakayasu ES, de Almeida IC & Schenkman S. Post-translational modifications of Trypanosoma cruzi histone H4. Mol Biochem Parasitol 2006; 150: 268-277.
79. Patterson SD & Aebersold RH. Proteomics: the first decade and beyond. Nat Genet 2003; 33(Suppl): 311-323.
80. Washburn MP, Wolters D & Yates JR III. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001; 19: 242-247.
81. Alban A, David SO, Bjorkesten L, et al. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003; 3: 36-44.
82. Pratt JM, Simpson DM, Doherty MK, Rivers J, Gaskell SJ & Beynon RJ. Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes. Nat Protoc 2006; 1: 1029-1043.
83. Scheltema RA, Decuypere S, t'Kindt R, Dujardin JC, Coombs GH & Breitling R. The potential of metabolomics for Leishmania research in the post-genomics era. Parasitology 2010; 137: 1291-1302.
84. t'Kindt R, Scheltema RA, Jankevics A, et al. Metabolomics to unveil and understand phenotypic diversity between pathogen populations. PLoS Negl Trop Dis 2010; 4: e904.
85. t'Kindt R, Jankevics A, Scheltema RA, et al. Towards an unbiased metabolic profiling of protozoan parasites: optimisation of a Leishmania sampling protocol for HILIC-orbitrap analysis. Anal Bioanal Chem 2010; 398: 2059-2069.
86. Barrett MP, Bakker BM & Breitling R. Metabolomic systems biology of trypanosomes. Parasitology 2010; 137: 1285-1290.
87. Kanehisa M & Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28: 27-30.
88. Kanehisa M, Goto S, Hattori M, et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 2006; 34: D354-D357.
89. Kanehisa M, Goto S, Furumichi M, Tanabe M & Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010; 38: D355-D360.
90. Karp PD, Paley SM, Krummenacker M, et al. Pathway Tools version 13.0: integrated software for pathway/genome informatics and systems biology. Brief Bioinform 2010; 11: 40-79.
91. Cottret L, Wildridge D, Vinson F, et al. MetExplore: a web server to link metabolomic experiments and genome-scale metabolic networks. Nucleic Acids Res 2010; 38: W132-W137.
92. Doyle MA, MacRae JI, De Souza DP, Saunders EC, McConville MJ & Likic VA. LeishCyc: a biochemical pathways database for Leishmania major. BMC Syst Biol 2009; 3: 57.
93. Bakker BM, Krauth-Siegel RL, Clayton C, et al. The silicon trypanosome. Parasitology 2010; 137: 1333-1341.
94. Stebbins CE. Structural microbiology at the pathogen-host interface. Cell Microbiol 2005; 7: 1227-1236.
95. Munter S, Way M & Frischknecht F. Signaling during pathogen infection. Sci STKE 2006; re5.
96. Oliver S. Guilt-by-association goes global. Nature 2000; 403: 601-603.
97. Eisenberg D, Marcotte EM, Xenarios I & Yeates TO. Protein function in the post-genomic era. Nature 2000; 405: 823-826.
98. Bartel PL, Roecklein JA, SenGupta D & Fields S. A protein linkage map of Escherichia coli bacteriophage T7. Nat Genet 1996; 12: 72-77.
99. Flajolet M, Rotondo G, Daviet L, et al. A genomic approach of the hepatitis C virus generates a protein interaction map. Gene 2000; 242: 369-379.
100. McCraith S, Holtzman T, Moss B & Fields S. Genome-wide analysis of vaccinia virus protein-protein interactions. Proc Natl Acad Sci USA 2000; 97: 4879-4884.
101. Uetz P, Giot L, Cagney G, et al. Pochart and others. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 2000; 403: 623-627.
102. Ito T, Tashiro K, Muta S, et al. Toward a protein-protein interaction map of the budding yeast: a comprehensive system to examine two-hybrid interactions in all possible combinations between the yeast proteins. Proc Natl Acad Sci USA 2000; 97: 1143-1147.
103. Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M & Sakaki Y. A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci USA 2001; 98: 4569-4574.
104. Walhout AJ, Sordella R, Lu X, et al. Protein interaction mapping in C. elegans using proteins involved in vulval development. Science 2000; 287: 116-122.
105. Li S, Armstrong CM, Bertin N, et al. A map of the interactome network of the metazoan C. elegans. Science 2004; 303: 540-543.
106. Giot L, Bader JS, Brouwer C, et al. A protein interaction map of Drosophila melanogaster. Science 2003; 302: 1727-1736.
107. Formstecher E, Aresta S, Collura V, et al. Protein interaction mapping: a Drosophila case study. Genome Res 2005; 15: 376-384.
108. Rain JC, Selig L, De RH, et al. The protein-protein interaction map of Helicobacter pylori. Nature 2001; 409: 211-215.
109. Stelzl U, Worm U, Lalowski M, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005; 122: 957-968.
110. Rual JF, Venkatesan K, Hao T, et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 2005; 437: 1173-1178.
111. Arifuzzaman M, Maeda M, Itoh A, et al. Large-scale identification of protein-protein interaction of Escherichia coli K-12. Genome Res 2006; 16: 686-691.
112. Parrish JR, Yu J, Liu G, et al. A proteome-wide protein interaction map for Campylobacter jejuni. Genome Biol 2007; 8: R130.
113. LaCount DJ, Vignali M, Chettier R, et al. A protein interaction network of the malaria parasite Plasmodium falciparum. Nature 2005; 438: 103-107.
114. Lacomble S, Portman N & Gull K. A protein-protein interaction map of the Trypanosoma brucei paraflagellar rod. PLoS ONE 2009; 4: e7685.
115. Schnaufer A, Wu M, Park YJ, et al. A protein-protein interaction map of trypanosome ∼20S editosomes. J Biol Chem 2010; 285: 5282-5295.
116. Rodriguez-Soca Y, Munteanu CR, Dorado J, Pazos A, Prado-Prado FJ & Gonzalez-Diaz H. Trypano-PPI: a web server for prediction of unique targets in trypanosome proteome by using electrostatic parameters of protein-protein interactions. J Proteome Res 2010; 9: 1182-1190.
117. Kumar D, Nath L, Kamal MA, et al. Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell 2010; 140: 731-743.
118. Brass AL, Dykxhoorn DM, Benita Y, et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008; 319: 921-926.
119. Konig R, Zhou Y, Elleder D, et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008; 135: 49-60.
120. Zhou H, Xu M, Huang Q, et al. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008; 4: 495-504.
121. Joshi-Tope G, Gillespie M, Vastrik I, et al. Reactome: a knowledgebase of biological pathways. Nucleic Acids Res 2005; 33: D428-D432.
122. Driscoll T, Dyer MD, Murali TM & Sobral BW. PIG - the pathogen interaction gateway. Nucleic Acids Res 2009; 37: D647-D650.
123. Davis FP, Barkan DT, Eswar N, McKerrow JH & Sali A. Host pathogen protein interactions predicted by comparative modeling. Protein Sci 2007; 16: 2585-2596.
124. Dyer MD, Murali TM & Sobral BW. Computational prediction of host-pathogen protein-protein interactions. Bioinformatics 2007; 23: i159-i166.
125. Dyer MD, Murali TM & Sobral BW. The landscape of human proteins interacting with viruses and other pathogens. PLoS Pathog 2008; 4: e32.
126. Archakov AI, Govorun VM, Dubanov AV, et al. Protein-protein interactions as a target for drugs in proteomics. Proteomics 2003; 3: 380-391.